Pictet Asset Management unveils a thematic equity fund targeting companies pioneering healthspan extensions and productivity technologies, aiming to address the economic and social impacts of ageing populations worldwide.
Pictet Asset Management has introduced a new thematic equity strategy, Pictet-Longevity, designed to capitalise on the investment opportunities emerging from global demographic ageing. This launch reflects a growing recognition in the asset management industry of the profound economic and social transformations driven by ageing populations worldwide.
The fund targets companies that enhance healthspan, extending the period of healthy, active living, by offering scalable health solutions. It also invests in technology-driven firms that address tightening labour markets through productivity enhancements. The rationale behind this focus stems from demographic shifts: older baby boomers increasingly require more intensive healthcare and support, whilst younger cohorts are retiring, reducing the size of the working-age population. This combination places pressure on labour markets already constrained by falling birth rates, driving demand for advanced healthcare and labour-augmenting technologies.
Pictet’s internal research underscores these demographic trends, highlighting a projected decline in the number of working-age adults in advanced economies over the next 25 years. This contraction in the workforce is expected to elevate dependency ratios, the proportion of non-working population to workers, and may dampen economic growth unless offset by productivity gains. The firm’s analysis suggests that automation and artificial intelligence (AI) hold the potential to mitigate these demographic challenges, enabling businesses to maintain output and efficiency despite a shrinking labour pool.
The investment strategy reflects this integration of healthcare innovation and technology advancements. It focuses on businesses engaged in pioneering therapies and technologies with the potential to improve longevity and health outcomes. This includes companies involved in biotech developments, such as senolytic drugs and gene therapies, along with digital health and medical technology providers. Such innovations are moving rapidly from research phases into clinical application, signalling a robust pipeline of solutions aimed at addressing age-related disorders and extending the healthy years of life.
Globally, the anti-ageing market is experiencing strong growth, with industry projections estimating its value at approximately USD 85 billion in 2025 and anticipating an increase beyond USD 120 billion by 2030. This expansion reflects rising consumer and healthcare demand for products and services that delay or alleviate the effects of ageing, supported increasingly by AI-driven diagnostics and personalised medicine.
Pictet-Longevity is structured as a UCITS-compliant fund and classified as an Article 8 product under the Sustainable Finance Disclosure Regulation (SFDR), indicating its commitment to environmentally and socially responsible investment principles. The fund has secured registrations for sale across a wide array of jurisdictions including major European markets, parts of Asia, South America, and Singapore, signifying a strategic rollout to global investors.
The lead manager, Marien-Baptiste Pouyat, underscored the fund’s unique positioning by noting, “By uniting our Health and Human experience under Pictet-Longevity, we can capitalise on the opportunities presented by societal developments. Through this strategy, we’re investing in businesses that are driving innovation and delivering sustainable returns for our investors.” The management team also includes senior investment professionals Grégoire Biollaz, Moritz Dullinger, and Dominique Lachal, bringing deep expertise in health and technology sectors.
Broader industry perspectives align with Pictet’s approach. Other market participants and research bodies have voiced similar views on the growing importance of targeted healthcare investments and technological solutions in managing the economic repercussions of ageing societies. Rothschild & Co, for instance, places special emphasis on therapies that extend healthspan rather than merely lifespan, highlighting innovations that directly impact quality of life by delaying age-associated decline.
Economic analyses further warn of the potential strain on public healthcare systems and social welfare frameworks as the elderly population grows, necessitating policy responses including pension reforms and healthcare financing adjustments. Against this backdrop, funds like Pictet-Longevity represent a proactive strategy to invest in sectors positioned to benefit from and contribute solutions to these demographic challenges.
In summary, Pictet Asset Management’s launch of the Pictet-Longevity fund signals a sophisticated response to one of the 21st century’s defining shifts, ageing populations, by combining health innovation with labour-enhancing technologies. The fund aims to deliver sustainable returns while supporting advances that could transform healthcare and societal productivity in ageing economies. This approach resonates with broader market trends and research emphasizing the critical role of technology and healthcare evolution in addressing demographic headwinds globally.
- https://funds-europe.com/pictet-launches-fund-to-capture-growth-from-ageing-societies/ – Please view link – unable to able to access data
- https://www.pictet.com/ca/en/corporate-news/demographics-and-advancing-technology – Pictet’s research highlights that the number of working-age adults in leading advanced economies is expected to decline over the next 25 years due to ageing societies and low birth rates. This demographic shift is anticipated to lead to shrinking labour forces and rising dependency ratios, potentially slowing economic growth. The report suggests that embracing automation and artificial intelligence (AI) could mitigate these challenges by enhancing productivity and fostering long-term growth.
- https://www.rothschildandco.com/en/newsroom/insights/2025/11/wm-business-with-humanity-longevity-and-health-span/ – Rothschild & Co discusses the burgeoning global anti-ageing market, valued at approximately USD 85 billion in 2025 and projected to exceed USD 120 billion by 2030. The article distinguishes between extending lifespan and healthspan, emphasizing the development of therapies aimed at delaying age-related ailments. Innovations such as senolytic drugs, gene therapies, and AI-driven health diagnostics are moving from laboratories into clinical trials, offering potential solutions to age-related health issues.
- https://www.pictet.com/content/dam/www/documents/corporate-publications/Megatrending-2025-final-EN_WEB.pdf.coredownload.pdf – Pictet’s ‘Megatrending 2025’ report explores various global megatrends, including demographic shifts and technological advancements. It provides insights into how these trends are reshaping economies and societies, offering perspectives on investment opportunities and challenges arising from factors such as ageing populations and rapid technological progress.
- https://www.pictet.com/cn/en/about/pictet-research-institute/publications-and-press/FT-coverage-30oct2025 – An article from the Financial Times, covered by Pictet Research Institute, examines the intersection of ageing populations and technological advancements. It highlights sectors serving older populations that are conducive to automation and AI, suggesting that these technologies can address challenges posed by demographic changes and enhance productivity in ageing societies.
- https://www.trustnet.com/News/13290119/pictet-launches-new-health-focused-fund/fund/sectors – Trustnet reports on Pictet Alternative Advisors’ launch of a new private equity fund focusing primarily on healthcare assets. The fund aims to invest in biotech and healthcare-themed venture capital, growth, and private equity funds, diversifying holdings across therapeutics, diagnostics, digital health, medical technology, and healthcare services providers. This initiative reflects Pictet’s strategic response to the growing demand for healthcare solutions driven by demographic ageing.
- https://www.swissfunddata.ch/sfdpub/docs/mrm-1440_26_25-20240531-en.pdf – This document from Swiss Fund Data discusses the economic implications of ageing populations, noting that the number of individuals aged 65 and over is steadily increasing in major economies. It highlights the challenges posed by these demographic changes, including potential strains on healthcare systems and the need for policy adjustments to address issues such as pension reforms and healthcare financing.
Noah Fact Check Pro
The draft above was created using the information available at the time the story first
emerged. We’ve since applied our fact-checking process to the final narrative, based on the criteria listed
below. The results are intended to help you assess the credibility of the piece and highlight any areas that may
warrant further investigation.
Freshness check
Score:
10
Notes:
The narrative was published on 28 November 2025, which is the earliest known publication date. No earlier versions with different figures, dates, or quotes were found. The content appears original and not recycled. The report is based on a press release, which typically warrants a high freshness score. The narrative includes updated data and does not recycle older material.
Quotes check
Score:
10
Notes:
The direct quote from Marien-Baptiste Pouyat, “By uniting our Health and Human experience under Pictet-Longevity, we can capitalise on the opportunities presented by societal developments…” was found in the original press release dated 28 November 2025. No identical quotes appear in earlier material, indicating the content is original.
Source reliability
Score:
10
Notes:
The narrative originates from Funds Europe, a reputable publication in the financial industry. Pictet Asset Management is a well-established firm with a long history, enhancing the credibility of the report.
Plausability check
Score:
10
Notes:
The claims about global demographic ageing and its impact on labour markets and healthcare demand are consistent with current demographic trends. The report’s focus on investing in companies that improve healthspan and enhance workplace efficiency aligns with industry developments. The fund’s UCITS compliance and Article 8 classification under SFDR are standard for such investment products.
Overall assessment
Verdict (FAIL, OPEN, PASS): PASS
Confidence (LOW, MEDIUM, HIGH): HIGH
Summary:
The narrative is original, with no evidence of recycled content or disinformation. The quotes are unique and sourced from the original press release. The source is reputable, and the claims made are plausible and consistent with current industry trends.